Disclosure Table

Summary by AI BETAClose X

The Takeover Panel has updated its Disclosure Table, noting the identification of Ingredion Incorporated as the offeror for Tate & Lyle plc, with an offer period commencement on May 14, 2026, and a Rule 2.6 deadline of June 11, 2026. Additionally, Funds advised by Toscafund Asset Management LLP have been identified as the offeror for Spire Healthcare Group plc, with an offer period commencement on September 18, 2025, and a Rule 2.6 deadline of June 11, 2026. No dealings or positions disclosure is required for these offerors.

Disclaimer*

Companies

Tate & Lyle (TATE)
UK 100

Latest directors dealings